Meet the speakers
Get ready to experience an outstanding lineup of speakers representing world-class universities and leading global companies such as Roche, and AstraZeneca. These distinguished professionals bring together a powerful combination of in-depth scientific expertise, pioneering research, and practical insights. From groundbreaking academic discoveries to transformative real-world innovations, our speakers will share knowledge that not only informs but also inspires. Expect thought-provoking presentations, fresh perspectives, and engaging discussions that foster meaningful exchange across disciplines. Whether you're looking to deepen your understanding, spark new ideas, or connect with forward-thinking minds, this event offers a unique opportunity to be part of a dynamic and intellectually stimulating environment. Don’t miss your chance to join the conversation and shape the future.
.png "Allen.png")
Prof. Christine Allen Ph.D.
University of Toronto, Canada
Christine Allen is a globally recognized researcher, leader, and entrepreneur. She is a Full Professor at the University of Toronto and Co-Founder and CEO of Intrepid Labs, which uses AI and robotics to accelerate drug formulation development. With over 180 publications, she is an expert in drug formulation and collaborates extensively with clinical and industry partners.
Specialties: Nanomedicine, Drug Delivery Systems, Formulation Development, Translational Research.
James Mann Ph.D.
AstraZeneca, United Kingdom
With a Ph.D. in Forensic and Analytical Chemistry, James Mann began his career at MSD before moving to AstraZeneca, where he progressed into senior leadership roles. He has led analytical teams and global development programs, focusing on in vitro product performance and cutting-edge analytical technologies. His expertise spans biorelevant dissolution, chromatography, and formulation development.
Specialties: Biorelevant Dissolution, Chromatography, Innovative Dissolution Technology.
.png "D'Arcy.png")
Prof. Deirdre D'Arcy Ph.D.
A unique blend of clinical pharmacy expertise and pharmaceutical technology research defines Deirdre D’Arcy’s career. She is a qualified pharmacist with postgraduate diplomas in Clinical Pharmacy and Quality Improvement and holds a PhD in Pharmaceutical Technology. Since 2005, she has driven innovations in integrated pharmacy education and technology-enhanced learning, while leading international research projects on computational modeling and personalized medicine.
Specialties: Dissolution Science, Pharmacokinetics, Pharmaceutical Process Simulation, AI in Pharmaceutics.
.png "Beyssac.png")
Prof. Eric Beyssac Ph.D.
University of Clermont Ferrand, France
Eric Beyssac holds a Master in Pharmacy and a Ph.D. in Pharmaceutical Technology from the Faculty of Pharmacy in Clermont-Ferrand, where he is now Professor in Biopharmaceutics and Pharmaceutical Technology. He has served as an invited professor at Université Laval in Québec and currently leads the in vitro study platform within the MEDIS research group.
Specialties: IVIVC, Dissolution Testing, Sustained-Release Formulation Development, Analytical Techniques.
Prof. Nikoletta Fotaki Ph.D.
University of Bath, United Kingdom
Nikoletta Fotaki is a pharmacist with advanced degrees in Toxicology and Pharmaceutical Technology. She has held roles in clinical practice, regulatory agencies, and academia, including postdoctoral fellowships in Greece and the USA. Her research focuses on predicting oral drug absorption through in vitro screening tools, software development, and in vitro–in vivo correlations.
Specialties: Drug Absorption, Biopharmaceutics, PBPK Modeling, IVIVC, Biorelevant Dissolution, Dissolution Imaging.
.png "Wacker.png")
Prof. Matthias G. Wacker Ph.D.
University of Leuwen, Netherlands
Matthias Wacker is Associate Professor at the National University of Leuwen and Co-Founder of Dissometrx. He previously led pharmaceutical technology at Fraunhofer IME in Germany. His research focuses on nanocarrier drug delivery, PBPK modeling, and biopredictive release methods. He actively contributes to global standards for nanotechnology and predictive pharmaceutical testing.
Specialties: Nanocarrier Design, PBPK Modeling, IVIVC, Biopredictive Release Methods, Nanomaterial Regulation, Quantitative Biopharmaceutics.